We are live on
!
Find out more
TA
TLS Advisors Portfolio holdings
AUM
$42.1M
1-Year Est. Return
25.99%
This Fund
S&P 500
This Quarter
Est. Return
+8%
1 Year Est. Return
+25.99%
3 Year Est. Return
+65.03%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.3M
AUM Growth
+$7.38M
(+18%)
Cap. Flow
+$4.14M
Cap. Flow
% of AUM
8.75%
Top 10 Holdings %
Top 10 Hldgs %
93.64%
Holding
20
New
1
Increased
4
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHP
BHP
|
+$1.77M |
| 2 |
EQT Corp
EQT
|
+$1.61M |
| 3 |
Vale
VALE
|
+$965K |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$192K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$10K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ovid Therapeutics
OVID
|
+$370K |
| 2 |
Alset
AEI
|
+$18K |
| 3 |
XOMA
Xoma
XOMA
|
+$16.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 50.7% |
| 2 | Energy | 18.46% |
| 3 | Healthcare | 14.22% |
| 4 | Communication Services | 12.81% |
| 5 | Consumer Discretionary | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BHP
BHP
$215B
| $9.69M | 20.47% |
155,960
+32,000
| +26% | +$1.77M |
|
2
Rio Tinto
RIO
$150B
| $7.34M | 15.5% |
103,100
| – | – |
|
|
3
EQT Corp
EQT
$33.8B
| $7.26M | 15.34% |
198,200
+47,400
| +31% | +$1.61M |
|
4
Meta Platforms (Facebook)
META
$1.59T
| $6.06M | 12.81% |
10,589
| – | – |
|
|
5
Vale
VALE
$63.2B
| $5.77M | 12.19% |
494,000
+90,000
| +22% | +$965K |
|
|
XOMA
6
DELISTED
Xoma
XOMA
| $3.17M | 6.7% |
119,744
-621
| -0.5% | -$16.8K |
|
7
Range Resources
RRC
$9.06B
| $1.47M | 3.11% |
47,923
| – | – |
|
8
Xenon Pharmaceuticals
XENE
$6.4B
| $1.3M | 2.74% |
32,956
| – | – |
|
9
Nucor
NUE
$53.7B
| $1.2M | 2.54% |
8,000
| – | – |
|
10
OmniAb
OABI
$306M
| $1.06M | 2.24% |
250,185
| – | – |
|
|
11
Ovid Therapeutics
OVID
$444M
| $910K | 1.92% |
771,531
-353,765
| -31% | -$370K |
|
12
Hovnanian Enterprises
HOV
$771M
| $791K | 1.67% |
3,872
| – | – |
|
13
Weyerhaeuser
WY
$17.2B
| $508K | 1.07% |
15,000
| – | – |
|
14
iShares MSCI Singapore ETF
EWS
$1.03B
| $301K | 0.64% |
13,600
| – | – |
|
|
15
Regeneron Pharmaceuticals
REGN
$68.3B
| $272K | 0.57% |
259
+9
| +4% | +$10K |
|
|
16
State Street Materials Select Sector SPDR ETF
XLB
$8.43B
| $203K | 0.43% |
+4,200
| New | +$192K |
|
|
ENZ
17
DELISTED
Enzo Biochem, Inc.
ENZ
| $15K | 0.03% |
13,616
| – | – |
|
18
Retractable Technologies
RVP
$20.4M
| $9K | 0.02% |
12,152
| – | – |
|
|
19
Alset
AEI
$42.8M
| – | – |
-11,140
| Closed | -$18K |
|
|
NBIS
20
Nebius Group N.V.
NBIS
$55.4B
| $0 | ﹤0.01% |
17,811
| – | – |
|
Similar funds
ACM
VEPM
SIM
FDG
GC
LSA
VAM
VI
TLS Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, TLS Advisors held 20 positions worth $47.3M, up 18% from $40M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
TLS Advisors deployed $4.14M of net new capital in Q3 2024, opening 1 new position and adding to 4 existing holdings. Its largest new stake was State Street Materials Select Sector SPDR ETF: 4,200 shares worth $203K.
By sector, the portfolio is most concentrated in Materials at 51% of assets, up from 49% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Ovid Therapeutics, an estimated $370K trimmed.
- TLS Advisors's largest Q3 2024 buy was State Street Materials Select Sector SPDR ETF: 4,200 shares worth $203K.
- TLS Advisors added most to BHP in Q3 2024, an estimated $1.77M increase.
- TLS Advisors's biggest Q3 2024 reduction was Ovid Therapeutics, cutting an estimated $370K.
- TLS Advisors fully exited Alset in Q3 2024, selling an estimated $18K.
- TLS Advisors's ten largest holdings make up 94% of its $47.3M portfolio in Q3 2024.
- TLS Advisors opened 1 new position and closed 1 in Q3 2024.
- TLS Advisors's portfolio value rose 18% quarter-over-quarter to $47.3M.
Based on TLS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.